Replaces Prod. #: ALX-350-251
Potent and selective inhibitor of CDKs. Selective for CDK1/cyclin B kinase (IC50=450nM) [2], CDK2 (IC50=700nM) [4] and CDK5/p35 (IC50=160nM) [4,5]. More potent than olomoucine (Prod. No. BML-CC200). Inhibits M phase promoting factor (MPF) kinase activity. Has effects on calcium channel gating.
Product Specification
Alternative Name: 6-Benzylamino-2-(R)-[(1-ethyl)-2-hydroxyethylamino]-9-isopropylpurine, 2(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
Formula: C19H26N6O
MW: 354.5
Purity: ≥95% (TLC)
Appearance: White solid.
CAS: 186692-46-6
Solubility: Soluble in DMSO.
Shipping: AMBIENT
Short Term Storage: +4°C
Long Term Storage: -20°C
Use/Stability: Stable for at least 1 year after receipt when stored, as supplied, at -20°C. Stock solutions are stable for up to 3 months at -20°C.